What is Genetic lens and zonula anomaly?
Genetic lens and zonula anomaly (Orphanet code 183607) is a broad classification category encompassing a group of rare inherited eye disorders that affect the crystalline lens and the zonular fibers (zonules of Zinn) that suspend the lens within the eye. The zonular fibers are delicate thread-like structures that connect the lens to the ciliary body, playing a critical role in maintaining lens position and enabling accommodation (the ability to focus at different distances). Anomalies in these structures can lead to a range of ocular manifestations including ectopia lentis (displacement or subluxation of the lens), microspherophakia (abnormally small, spherical lens), lens coloboma, and various forms of congenital cataracts. These conditions primarily affect the visual system and can result in significant visual impairment if untreated. Symptoms may include blurred vision, myopia (nearsightedness), astigmatism, and in cases of significant lens displacement, monocular diplopia (double vision in one eye) or even secondary glaucoma. Some genetic lens and zonula anomalies occur as isolated ocular findings, while others may be part of broader systemic syndromes such as Marfan syndrome, Weill-Marchesani syndrome, or homocystinuria, where connective tissue abnormalities affect multiple organ systems including the skeletal and cardiovascular systems. Treatment depends on the specific anomaly and its severity. Mild cases may be managed with corrective lenses or contact lenses. More severe cases, particularly those involving significant lens subluxation or dislocation, may require surgical intervention including lensectomy (lens removal) with intraocular lens implantation. Regular ophthalmologic monitoring is essential, and when a systemic syndrome is suspected, comprehensive genetic evaluation and multidisciplinary care are recommended. Genetic counseling is important for affected families, as the inheritance pattern varies depending on the specific underlying genetic cause.
- Inheritance
- Variable
- Can be inherited in different ways depending on the underlying gene
- Age of Onset
- Variable
- Can begin at different ages, from infancy through adulthood
Treatments
Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly
No FDA-approved treatments are currently listed for Genetic lens and zonula anomaly.
View clinical trials →Clinical Trials
View all trials with filters →Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest
No actively recruiting trials found for Genetic lens and zonula anomaly at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)
No specialists are currently listed for Genetic lens and zonula anomaly.
Treatment Centers
8 centersSource: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months
Children's Hospital Colorado Rare Disease Program ↗
Children's Hospital Colorado
📍 Aurora, CO
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDBoston Children's Hospital Rare Disease Program ↗
Boston Children's Hospital
📍 Boston, MA
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
🏨 Children'sAnn & Robert H. Lurie Children's Hospital Genetics ↗
Lurie Children's Hospital
📍 Chicago, IL
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDCincinnati Children's Hospital Medical Center ↗
Cincinnati Children's
📍 Cincinnati, OH
👤 Boston Children's Hospital Rare Disease Program
🏨 Children'sNationwide Children's Hospital Rare Disease Center ↗
Nationwide Children's Hospital
📍 Columbus, OH
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to Genetic lens and zonula anomaly.
Community
No community posts yet. Be the first to share your experience with Genetic lens and zonula anomaly.
Start the conversation →Latest news about Genetic lens and zonula anomaly
Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC
No recent news articles for Genetic lens and zonula anomaly.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Genetic lens and zonula anomaly
What is Genetic lens and zonula anomaly?
Genetic lens and zonula anomaly (Orphanet code 183607) is a broad classification category encompassing a group of rare inherited eye disorders that affect the crystalline lens and the zonular fibers (zonules of Zinn) that suspend the lens within the eye. The zonular fibers are delicate thread-like structures that connect the lens to the ciliary body, playing a critical role in maintaining lens position and enabling accommodation (the ability to focus at different distances). Anomalies in these structures can lead to a range of ocular manifestations including ectopia lentis (displacement or sub
Frequently asked questions about Genetic lens and zonula anomaly
Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.
What is Genetic lens and zonula anomaly?
Genetic lens and zonula anomaly is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:183607). It is typically inherited as variable. Age of onset is generally variable. For verified primary sources, see the UniteRare Genetic lens and zonula anomaly page.
How is Genetic lens and zonula anomaly inherited?
Genetic lens and zonula anomaly follows variable inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.
Are there FDA-approved treatments for Genetic lens and zonula anomaly?
Approved treatments for Genetic lens and zonula anomaly are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.
Are there clinical trials for Genetic lens and zonula anomaly?
Active clinical trials for Genetic lens and zonula anomaly are tracked daily from ClinicalTrials.gov. Trial availability changes frequently; check the UniteRare trial listings for the current count and recruitment status. Sponsors of rare-disease research often welcome inquiries even when a trial is not actively recruiting at a given moment.
How do I find a specialist for Genetic lens and zonula anomaly?
Verified Genetic lens and zonula anomaly specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.
See full Genetic lens and zonula anomaly page for complete clinical details, sources, and verified-specialist listings.
Cite this page
Select a citation format above to view and copy.